DEVELOPMENT AND VALIDATION OF UV-VISIBLE SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DULOXETINE

  • LIPSA SAMAL Department of Pharmacy, College of Pharmaceutical Sciences, Puri 752002, Odisha, India
  • AMARESH PRUSTY Department of Pharmacy, College of Pharmaceutical Sciences, Puri 752002, Odisha, India http://orcid.org/0000-0002-2978-8044

Abstract

Objective: The aim of the present work was to develop and validate a simple UV spectroscopic method for the determination of duloxetine, which is a thiophene derivative and a selective neurotransmitter reuptake inhibitor for serotonin, norepinephrine, and to lesser degree dopamine.


Methods: The UV Spectrophotometric analysis was performed using Shimadzu UV-1800 and Shimadzu UV-1700 spectrophotometer by using solvent system acetonitrile and water in the ratio of 8:2. Detection was performed at a wavelength of 290 nm. Method validation was carried out according to ICH Q2R1 guidelines by taking the parameters linearity, accuracy, precision, ruggedness, and robustness, LOD and LOQ.


Results: The UV Spectrophotometric method was found linear in the range of 10-50 μg/ml. The method was rugged and robust with % relative standard deviation less than 2. The extraction recoveries were found to be higher than 99% in all experimental conditions.


Conclusion: Based upon the performance characteristics, the proposed method was found accurate, precise and rapid and suitable for the determination of Duloxetine for routine analysis.

Keywords: Duloxetine, UV Spectrophotometric method, Beer’s Law, Process validation, ICH guidelines

Downloads

Download data is not yet available.

References

1. Remington. The science and practice of pharmacy. Edited by Loyd V, Allen Jr, PhD, RPh, Published by Pharmaceutical Press, 1 Lambeth High Street, London SE1 7JN, UK, University city science Center, 3624 Market Street, Suite 5E, Philadelphia, PA 19104, USA, volume-1, Twenty-second edition, 1416; 2013.
2. The Merck Index: an encyclopedia of chemicals, drugs, biological. Edited. MJO Neil, Merck and Co., Inc. Merck Research laboratories, Whitehouse station, NJ, USA. 14th edition; 2006. p. 3466.
3. Drug Today, July-September; 2017. p. 502.
4. HP Rang, JM Ritter, RJ Flower. Rang and Dale’s pharmacology, Elsevier Churchill Livingstone publication, china. 8th edition; 2016. p. 569-77.
5. Tripathy KD. Essentials of medical pharmacology, jaypee brothers medical publishers (P) Ltd. 7th edition. Newdelhi, Ansari Road, Daryaganj; 2013. p. 441-3.
6. Skinner MH, Kuan HY, Pan A, Sathirakul K, Knadler MP, Gonzales CR, et al. duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers. Clin Pharmacol Ther 2003;73:170–7.
7. Lantz RJ, Gillespie TA, Rash TJ, Kuo F, Skinner M, Kuan HY, et al. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Metab Dispos 2003;31:1142–50.
8. Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, et al. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. Bioorg Med Chem Lett 2003;13:4477–80.
9. Xiangping Liu, Yingxiang Du, Xiulan Wu. Simple UV spectrophotometric determination of duloxetine hydrochloride in bulk and in pharmaceutical formulations. Spectrochim Acta Part A 2008;71:915-20.
10. Prabhu SL, Shahnawaz S, Dinesh Kumar C, Shirwaikar A. Spectrofluorimetric method for determination of duloxetine hydrochloride in bulk and pharmaceutical dosage forms. Indian J Pharm Sci 2008;70:502-3.
11. Yunoos M, Sankar DG, kumar BP, Hameed S. Simple UV spectrophotometric determination of duloxetine hydrochloride in bulk and in pharmaceutical. E-J Chem 2010;7:785-8.
12. Sydabi P, Muneer S, Ishaq BM, Kumar ES. Development and validation of an analytical method for duloxetine hydrochloride in capsule formulations by HPLC-UV. Indo Am J Pharm Sci 2014;1:11-6.
13. Methuku K, Aarelly K, Raghunandan N. Simple UV spectrophotometric determination of duloxetine hydrochloride in bulk and in pharmaceutical formulations. J Pharm Sci Innovation 2012;1:81-6.
Statistics
58 Views | 149 Downloads
How to Cite
SAMAL, L., and A. PRUSTY. “DEVELOPMENT AND VALIDATION OF UV-VISIBLE SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DULOXETINE”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 11, no. 3, Jan. 2019, pp. 27-31, doi:10.22159/ijpps.2019v11i3.30981.
Section
Original Article(s)